Cargando…

Producing and evaluating a novel lentiviral vector for β-thalassaemia gene therapy

Detalles Bibliográficos
Autores principales:	Bokinni, Y, Kao, V, García-Gómez, M, Antoniou, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3426033/ http://dx.doi.org/10.1186/1753-6561-6-S4-O15

Ejemplares similares

Epistasis and the sensitivity of phenotypic screens for beta thalassaemia
por: Penman, Bridget, et al.
Publicado: (2014)

Worldwide survey of T2* cardiovascular magnetic resonance in Thalassaemia
por: Carpenter, John-Paul, et al.
Publicado: (2011)

Assessing the impact of lentiviral vector integration on splicing of cellular genes at the genome-wide level
por: Montini, Eugenio, et al.
Publicado: (2011)

Autologous T-cell therapy based on a lentiviral vector expressing long antisense RNA targeted against HIV-1 env gene influences HIV replication and evolution in vivo
por: Pasternak, Alexander, et al.
Publicado: (2013)

Production of lentiviral vectors using novel, enzymatically produced, linear DNA
por: Karda, Rajvinder, et al.
Publicado: (2019)

Echocardiographic evaluation of changes in diastolic dysfunction after CABG surgery, effect of novel therapy with Ivabradine
por: Panayotova, D, et al.
Publicado: (2013)

Development of lentiviral vectors for gene therapy of arthritis
por: Militello, M, et al.
Publicado: (2001)

Molecular bioactivity extrapolation to novel targets by support vector machines
por: Van Westen, Gerard JP, et al.
Publicado: (2010)

Ultrafast CMR to deliver high volume screening of an at risk thalassemia population in the developing world: preliminary results from the TIC-TOC study (Thailand and UK international collaboration in thalassaemia using an optimised ultrafast CMR protocol)
por: Abdel-Gadir, Amna, et al.
Publicado: (2016)

Evaluating statistical characteristics of biomarker-guided trial designs
por: Antoniou, Miranta, et al.
Publicado: (2015)

Endocrine complications in patients with thalassaemia major
por: Meng, Zhe, et al.
Publicado: (2013)

Factors affecting height in children and adolescents with transfusion-dependent Thalassaemia – results from a Thalassaemia center in Malaysia
por: Ting, Tzer Hwu, et al.
Publicado: (2013)

Lentiviral Vectors for Ocular Gene Therapy
por: Arsenijevic, Yvan, et al.
Publicado: (2022)

Lentiviral Vector Bioprocessing
por: Perry, Christopher, et al.
Publicado: (2021)

Kynurenine is a novel endothelium-derived vascular relaxing factor produced during inflammation
por: Wang, Yutang, et al.
Publicado: (2009)

Simian immunodeficiency virus-Vpx as an adjuvant for integrase defective lentiviral vector-based vaccines
por: Blasi, M, et al.
Publicado: (2012)

Targeting non-viral vectors to tumor cells and the tumor microenvironment
por: Moura, Vera, et al.
Publicado: (2010)

Production of lentiviral vectors
por: Merten, Otto-Wilhelm, et al.
Publicado: (2016)

Gene Therapy Applications of Non-Human Lentiviral Vectors
por: Munis, Altar M.
Publicado: (2020)

Lentiviral Vectors and Cystic Fibrosis Gene Therapy
por: Castellani, Stefano, et al.
Publicado: (2010)

Phlebotomine sand flies on the crossroads of Anatolia: transmitted diseases and vectors
por: Kasap Erisoz, O, et al.
Publicado: (2014)

Engineering mosquito population for vector control
por: Windbichler, Nikolai, et al.
Publicado: (2012)

Vector borne pathogens and host complement system: a tangled tale
por: Bhide, M, et al.
Publicado: (2014)

Adenovirus vectors from various serotypes induce distinct cytokine profiles
por: Teigler, JE, et al.
Publicado: (2012)

Rapid protein profiling for arthropod vector identification
por: Mathis, A, et al.
Publicado: (2014)

Carbonic anhydrase-8 gene therapy inhibits the ITPR1-cytosolic free calcium pathway producing analgesia and anti-hyperalgesia
por: Levitt, Roy C, et al.
Publicado: (2014)

Generation of a lentiviral vector producer cell clone for human Wiskott-Aldrich syndrome gene therapy
por: Wielgosz, Matthew M, et al.
Publicado: (2015)

An Improved Protocol for the Production of Lentiviral Vectors
por: Brown, Logan Y., et al.
Publicado: (2020)

Vector-borne nematodes, emerging parasites in Finnish cervids
por: Laaksonen, Sauli, et al.
Publicado: (2010)

Tuberculosis reactivation during novel, biologic therapy
por: Popescu, Cristina, et al.
Publicado: (2013)

Measurement of lentiviral vector titre and copy number by cross-species duplex quantitative PCR
por: Christodoulou, I, et al.
Publicado: (2016)

Implementation of Novel Affinity Ligand for Lentiviral Vector Purification
por: Moreira, Ana Sofia, et al.
Publicado: (2023)

Viral vectored transmission blocking vaccines against Plasmodium falciparum
por: Kapulu, Melissa C, et al.
Publicado: (2010)

Beyond descriptor vectors: QSAR modelling using structural similarity
por: Zell, Andreas, et al.
Publicado: (2008)

Accelerated heterologous prime-boost adenovirus vector-based SIV vaccine in neonatal rhesus monkeys
por: Liu, J, et al.
Publicado: (2012)

The feasibility of incorporating Vpx into lentiviral gene therapy vectors
por: McAllery, Samantha A, et al.
Publicado: (2016)

Designing Lentiviral Vectors for Gene Therapy of Genetic Diseases
por: Poletti, Valentina, et al.
Publicado: (2021)

Toward lentiviral vectors for antiangiogenic ocular gene therapy
por: Askou, Anne Louise, et al.
Publicado: (2023)

Oxidative stress in β-thalassaemia and sickle cell disease
por: Voskou, S., et al.
Publicado: (2015)

P17-20. Lentiviral vector-based vaccine against SIV infection and simian AIDS
por: Beignon, A, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_8bc00os9uiftudtcpil31mi5pn